PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
Clinical trial NCT03763643 · COMPLETED
Trial details
- NCT number
- NCT03763643
- Sponsor
- University of Minnesota
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2025-02-07
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.